Key points are not available for this paper at this time.
Conversational AI-enhanced analysis reveals that SS is distinguished from other CTCL subtypes not by higher mutational load, but by qualitative differences in pathway involvement, particularly epigenetic dysregulation, immune escape, and transcriptional control. These findings generate testable hypotheses for downstream validation in patient-level datasets and demonstrate the utility of conversational AI agents as accelerators of translational cancer genomics.
Diaz et al. (Tue,) studied this question.